Michele De Tursi Selected Research

Anaplastic Lymphoma Kinase

1/2020

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michele De Tursi Research Topics

Disease

34	Neoplasms (Cancer) 01/2023 - 11/2010
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 10/2015
9	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2009
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 09/2014
5	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2010
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2016
5	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2007
4	Prostatic Neoplasms (Prostate Cancer) 04/2023 - 10/2017
4	Disease Progression 01/2023 - 11/2020
4	Overweight 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
2	Vomiting 01/2022 - 11/2014
2	Nausea 01/2022 - 11/2014
2	Human Influenza (Influenza) 01/2020 - 10/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2018 - 05/2012
2	Venous Thromboembolism 12/2016 - 11/2010
2	Thrombosis (Thrombus) 10/2015 - 04/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Exanthema (Rash) 03/2022
1	Pancytopenia 01/2022
1	Neutropenia 12/2021
1	Obesity 10/2020
1	Neuroendocrine Carcinoma 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Cysts 01/2020
1	Inflammation (Inflammations) 01/2020
1	Sarcopenia 01/2020
1	Fatigue 11/2019
1	Stomach Neoplasms (Stomach Cancer) 09/2019
1	Weight Loss (Weight Reduction) 09/2019
1	Body Weight (Weight, Body) 09/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Triple Negative Breast Neoplasms 03/2018

Drug/Important Bio-Agent (IBA)

12	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2018
6	pembrolizumabIBA 01/2023 - 10/2020
5	ErbB Receptors (EGF Receptor)IBA 03/2022 - 10/2015
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
3	Panitumumab (Vectibix)FDA Link 03/2022 - 09/2014
3	Cetuximab (Erbitux)FDA Link 03/2022 - 01/2017
3	Sunitinib (Sutent)FDA Link 01/2021 - 01/2016
3	Hormones (Hormone)IBA 01/2019 - 02/2013
3	Trastuzumab (Herceptin)FDA Link 11/2013 - 05/2009
2	Codon (Codons)IBA 01/2023 - 09/2014
2	AntiemeticsIBA 01/2022 - 11/2014
2	Opioid Analgesics (Opioids)IBA 01/2022 - 11/2020
2	Monoclonal AntibodiesIBA 12/2021 - 01/2019
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2019
2	AndrogensIBA 10/2020 - 10/2017
2	cabozantinibIBA 10/2020 - 01/2020
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 10/2018
2	Axitinib (AG 013736)IBA 01/2019 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2018 - 01/2017
2	Abiraterone AcetateIBA 11/2017 - 10/2017
2	Gefitinib (Iressa)FDA Link 01/2017 - 06/2007
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	trifluridine tipiracil drug combinationIBA 01/2023
1	NivolumabIBA 01/2023
1	Aprepitant (Emend)FDA Link 01/2022
1	netupitantIBA 01/2022
1	fosaprepitant FDA Link 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	osimertinibIBA 01/2022
1	Palonosetron (Aloxi)FDA Link 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Growth Factor ReceptorsIBA 12/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Long-Acting Thyroid Stimulator (LATS)IBA 01/2021
1	B7-H1 AntigenIBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	AnticoagulantsIBA 11/2020
1	SteroidsIBA 11/2020
1	pertuzumabIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	LigandsIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	CrizotinibIBA 01/2020
1	ORALIT (ORS)IBA 01/2020
1	alectinibIBA 01/2020
1	RamucirumabIBA 09/2019
1	exemestane (Aromasin)FDA Link 01/2019
1	palbociclibIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Everolimus FDA Link 01/2019
1	Nelfinavir (Viracept)FDA Link 09/2018
1	nitroxolineIBA 09/2018
1	PlatinumIBA 01/2018

Therapy/Procedure

20	Therapeutics 01/2023 - 05/2014
20	Drug Therapy (Chemotherapy) 01/2023 - 11/2010
14	Immunotherapy 01/2023 - 01/2018
3	Castration 04/2023 - 10/2017
3	Neoadjuvant Therapy 04/2019 - 02/2013
1	Drug Tapering 01/2022